NCT03791593 |
|
EVOlocumab in Stable Heart Failure With Reduced Ejection Fraction of Ischemic Etiology EVO-HF Pilot
|
View
|
NCT03984149 |
|
Lipa Gene Mutation in PED-LIPIGEN Pediatric FH Subjects
|
View
|
NCT05503095 |
|
PCSK9 Polymorphism and Risk of Cardiac Rupture
|
View
|
NCT05293535 |
|
Klotho _ LRP-6 _ Gastric Adenocarcinoma
|
View
|
NCT04485871 |
|
Targeting Risk Factors for Diabetes in Subjects With Normal Blood Cholesterol Using Omega-3 Fatty Acids
|
View
|
NCT02225340 |
|
Relationships Between Plasma PCSK9 Levels LDL-cholesterol Concentrations and Lipoprotein a Levels in Familial Hypercholesterolemia
|
View
|
NCT01783405 |
|
Cardiovascular Disease in FH Heterozygous
|
View
|
NCT04148001 |
|
Identifying and Genotyping Homozygous Familial Hypercholesterolemia HoFH Patients
|
View
|
NCT02651675 |
|
A Gene Therapy Study for Homozygous Familial Hypercholesterolemia HoFH
|
View
|
NCT06125847 |
|
NGGT006 Gene Therapy for Homozygous Familial Hypercholesterolemia
|
View
|
NCT01109706 |
|
Relevance of Plasma PCSK9 Concentration as a Biomarker in Acute Coronary Syndrome
|
View
|
NCT05218005 |
|
Advancing Cardiac Care Unit-based Rapid Assessment and Treatment of hypErcholesterolemia
|
View
|
NCT06220994 |
|
the Gut Microbiome and Metabolomics in Chronic Lower extreMities Threatening Ischemia
|
View
|
NCT05043181 |
|
Exosome-based Nanoplatform for Ldlr mRNA Delivery in FH
|
View
|
NCT06293729 |
|
Safety and Efficacy Study of NGGT006 in Refractory Hypercholesterolemia Patients
|
View
|
NCT03152656 |
|
A Registration Study for Familial Hypercholesterolemia in Taiwan
|
View
|